Navigation Links
Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program
Date:11/9/2009

ROCKVILLE, Md., Nov. 9 /PRNewswire/ -- OriGene Technologies, Inc. today announced Royal Institute of Technology in Sweden has adopted its VERIFY Tagged Antigen(TM) (Over-expression Lysates) in the Human Protein Atlas program. This program is funded by the Knut and Alice Wallenberg Foundation and is set up to explore the human proteome systematically using Antibody-Based Proteomics. "Generating high quality mono-specific antibodies in a high throughput manner is critical for the success of the program," commented Prof Mathias Uhlen, Program Director. "In a pilot testing using OriGene's over-expression cell lysates as Western blot positive controls, we were able to increase antibody validation success rate from 30% to 80%. We are extremely happy with the results and have decided to adopt these lysates in the official Human Protein Atlas program." Dr. Wei-Wu He, CEO of OriGene Technologies, commented, "We are honored to team up with a world renowned researcher like Prof. Uhlen. OriGene has built the most comprehensive cDNA clone collection. These over-expression lysates are the beginning of a series of products aimed at antibody validation and biomarker discovery. We are committed to provide both products and technical resource required by the Human Protein Atlas project."

About OriGene

OriGene Technologies, Inc., is a gene centric life sciences tool company dedicated to support academic, pharmaceutical and biotech companies in their research of gene functions and drug discovery. OriGene's novel product line includes the world's largest cDNA and shRNA clone collections, over 5,000 purified human proteins, high quality monoclonal antibodies to human proteins, 100,000 highly validated human tissues, and qPCR arrays. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is committed to its mission to be "
'/>"/>

SOURCE OriGene Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
2. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
3. Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
4. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
5. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
6. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
7. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
8. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
9. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
10. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , , NEW YORK, Nov. 19 ...d running noses is here. Here,s more on preparing ...cNeil-Janssen Pharmaceuticals Inc. at: ,, ht...RzdnRfCsbxc9R2VXAOIF ,, Medialink is a divis... access video, audio, text, graphics and photos at...
(Date:11/19/2009)... , , SCHAUMBERG, Ill., Nov. 19 /PRNewswi... flexible, PACS-neutral healthcare image managemen... agreement to provide a combined PACS- neutral arc... partner, Data Distributing, an international lead...hiving solutions to the medical industry. Under t...
(Date:11/19/2009)... , , PRINCETON, N.J., Nov. 19 /PRNewswir...sparing alternatives to traditional spinal fusion ...lon to its executive management team as the Vice P..., (Logo: http://www.newscom.com/cgi-bin/prnh/2...years of clinical and regulatory experience in the...
Breaking Medicine Technology:Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 1Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 2Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 3Chicago Lawyers Secure Record 2425 Million Cook County Jury Verdict for Schaumburg Accident Victim 57456 1Chicago Lawyers Secure Record 2425 Million Cook County Jury Verdict for Schaumburg Accident Victim 57456 2Dean MacCarter Ph D Addressed Differentiation of Responder vs Non Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting 57454 1Dean MacCarter Ph D Addressed Differentiation of Responder vs Non Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting 57454 2Dean MacCarter Ph D Addressed Differentiation of Responder vs Non Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting 57454 3Dean MacCarter Ph D Addressed Differentiation of Responder vs Non Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting 57454 4
... Nov. 14 Xenomics, Inc. (the,"Company") (OTC Pink...ation,medical DNA diagnostic technologies, announc...tection of nucleic acid sequences in urine," RE39,...nucleic acid technology in,the area of infectious ...cleic acids (Tr-DNA and Tr-RNA) are fragments of D...
...tudy to Demonstrate Survival Benefit with ERBITUX ...to All Approved Chemotherapies -, NEW YORK, Nov. ...and Bristol-Myers Squibb Company (NYSE: BMY ),ann...l, randomized Phase,III trial, published in the Ne... (cetuximab) as a single agent demonstrated a sign...
Other Medicine Technology:Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring 2Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring 3New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer 2New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer 3New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer 4New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer 5New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer 6New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer 7New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer 8
(Date:11/20/2009)... Nov. 20 Omnicell, Inc. ...tions to acute healthcare facilities, announced to...iper Jaffray Healthcare Conference at the New Yor...eakers: Randall A. Lipps, founder, chairman, pres... CFO ,, Date: Tuesday, December 1, 2009 ,,...
(Date:11/20/2009)...wswire-USNewswire/ -- The Senate,s newly released ...able Care Act") infringes on Americans, health-ins...ns, president of the Institute for Health Freedom ....C. ,, The bill would (among many other provis...to buy government-sanctioned health insurance; I...
(Date:11/20/2009)... Fear about the risk of...ients are not getting aortic valve replacement sur...iversity of Michigan Health System. ,, Earlier...edian Robin Williams underwent aortic valve replac...t on the potentially life-saving surgery. ,, In...
(Date:11/20/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue. ,, Imaging Agents - A Worldwide Market R...5/Imaging-Agents---A-Worldwide-Market-Review.html#...mpaign=prnewswire ,, Development of contrast ...within the human body. With their inherent ability...
(Date:11/20/2009)...RNewswire/ -- As we approach Thanksgiving and prep...people in Los Angeles sadly don,t have enough to e...m, that,s nearly the population of Philadelphia. C...gry - and the situation is getting worse as the un...Jewish Federation of Greater Los Angeles is Fed...
Breaking Medicine News(10 mins):Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:Senate Mandatory Health-Insurance Bill Infringes on Choice and Privacy 2Health News:Half of Eligible Patients Do Not Get Aortic Valve Replacement 2Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 2Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 4Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 5Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 6Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 7Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 8Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 9Health News:The Jewish Federation Unveils Blueprint to End Hunger in Los Angeles 2Health News:The Jewish Federation Unveils Blueprint to End Hunger in Los Angeles 3
...nce Inc. (NYSE: CVD ) today announced that it wi...h 2009 Health Care Conference on Thursday, May 14,...ive webcast of the presentation at www.covance.c...sey, is one of the world,s largest and most compre...
.../PRNewswire-Asia/ -- China Medicine Corporation,(O... Company"), a developer,and a leading distributor ...ls,traditional Chinese medicines (TCM), nutritiona...hlights:, -- Revenues increased 43% from Q1 of ...
...y 13 The very first thing many,people do when the...lves a,cup of coffee. The substance in the hot bre...e world: caffeine. Caffeine doesn,t only come from...stions of our Podcast listeners on Chemistry in ou...
...d Gastroenterologist Offers Tips for Treatment , ...13, 2009 -- As many as 90 million cases of acute g...ccording to eMedicine from WebMD. AGE, an infla...he most common response is to seek drugs that will...
...ientology Volunteer Ministers Goodwill Tour is t...d nation near Samoa in the South Pacific. , ... -- A Scientology Volunteer Ministers Goodwill T...sland of Tongatapu, Mathew Andrews, the leader of ...
...Leonard P. Berenholz, who invented an ear surgery ...y on May 29, 2009 in Phoenix, Arizona during the o...s entitled "Total Ossiculoplasty - The advant...eonard P. Berenholz, who invented an ear surgery p...
Other Medicine News:Health News:China Medicine Announces First Quarter 2009 Results 2Health News:China Medicine Announces First Quarter 2009 Results 3Health News:China Medicine Announces First Quarter 2009 Results 4Health News:China Medicine Announces First Quarter 2009 Results 5Health News:China Medicine Announces First Quarter 2009 Results 6Health News:China Medicine Announces First Quarter 2009 Results 7Health News:China Medicine Announces First Quarter 2009 Results 8Health News:China Medicine Announces First Quarter 2009 Results 9Health News:China Medicine Announces First Quarter 2009 Results 10Health News:China Medicine Announces First Quarter 2009 Results 11Health News:China Medicine Announces First Quarter 2009 Results 12Health News:China Medicine Announces First Quarter 2009 Results 13Health News:BASF Podcast: The Chemical Reporter - Why Does Caffeine Have a Stimulating Effect? 2Health News:BASF Podcast: The Chemical Reporter - Why Does Caffeine Have a Stimulating Effect? 3Health News:When Stomach Flu Strikes, Work With, Not Against, Body's Natural Defenses 2Health News:Scientology Volunteer Ministers Target Drug and Alcohol Abuse in the South Pacific 2Health News:Physician Admitted to Prestigious International Trilogic Society 2
Eppendorf Research Series 2100 Fixed-volume Pipette, 450 l
...s a synonym for pipetting accuracy, a smooth strok...ting comfort. Its single, multifunctional button i...t as well as eject the tip. Product features:Eppen...and precision. Ejection sleeve can be removed to f...
Finnpipette Focus Fixed Volume, 5000ul
Finnpipette Fixed Volume, 10mL
Medicine Products: